The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Application of chromosomal microarray analysis in products of miscarriage
Open accessAbstract
Chromosomal abnormality is one of the major cause of spontaneous abortion. Most available guidelines suggest genetic testing after three miscarriages, which has been proved to be difficult to adhere to and somewhat of low cost-effectiveness. As chromosomal microarray analysis has been recommended to be applied on miscarriage products, we managed a retrospective study on our experience investigate the potential impact of this technique on previous guidelines and our present management on miscarried couples and products. Of the 405 products of conceptions, the overall detection rate of pathogenetic results was 55.3% (224/405), including 7.1% (16/224) copy number changes which could be missed by conventional karyotyping analysis. Of the 222 natural conception samples, abnormal genetic results were found in 126 cases (56.8%). The detection rate in the assistant reproductive treatment group was 53.6% (98/183). No significant difference was found between these two groups ( p = 0.645, OR = 1.110 with 95% CI: 0.713–1.726). The detection rate was 53.2% (75/141) in 141 product-of-conceptions (POCs) of mothers with adverse pregnancy histories. Of the 264 POC samples of mothers without abnormal pregnancy histories, 56.4% (149/264) were genetically abnormal. The detection rate and maternal age between these two groups were all compatible. Chromosomal microarray testing should be referred to couples at their first miscarriage regardless of the way how they get pregnant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A review reported that approximately 50% of sporadic miscarriages are a result of fetal chromosome anomalies (pooled prevalence 49.7%; 95% CI 34.9-64.6%).”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Chromosome anomalies of the pregnancy are the commonest cause of both sporadic miscarriage and recurrent miscarriage.”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A study has shown that miscarriages following assisted reproductive treatment have rates of cytogenetic anomalies similar to sporadic miscarriages (56.8% versus 53.6%; OR 1.11, 95% CI 0.71-1.73).52”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among those with anomalies, in descending order of frequency were: trisomy (51.9%); polyploidy (18.8%); monosomy (15.2%); structural anomalies (6.5%); and others (7.6%).52”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is worth noting that with newer molecular techniques a further 5-7% submicroscopic variants may also be detected.52,54”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kearney, H. M., Thorland, E. C., Brown, K. K., Quintero-Rivera, F., & South, S. T. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182217a3a · Cited by 929
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Jauniaux, E. (2006) · Human Reproduction · doi:10.1093/humrep/del150 · Cited by 520
van den Berg, M. M. J., van Maarle, M. C., van Wely, M., & Goddijn, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.001 · Cited by 282
Trisomy Recurrence: A Reconsideration Based on North American Data
Warburton, D., Dallaire, L., Thangavelu, M., Ross, L., Levin, B., & Kline, J. (2004) · The American Journal of Human Genetics · doi:10.1086/423331 · Cited by 249
Levy, B., Sigurjonsson, S., Pettersen, B., Maisenbacher, M. K., Hall, M. P., Demko, Z., Lathi, R. B., Tao, R., Aggarwal, V., & Rabinowitz, M. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000325 · Cited by 244
Depression and emotional stress is highly prevalent among women with recurrent pregnancy loss
Kolte, A. M., Olsen, L. R., Mikkelsen, E. M., Christiansen, O. B., & Nielsen, H. S. (2015) · Human Reproduction · doi:10.1093/humrep/dev014 · Cited by 205 · cited 1×
“Researchers have also found that women with recurrent pregnancy loss (RPL) suffered from more psychological stress and depression [7, 15, 19], which could trigger a negative feedback [8] threatening subsequent conception [17, 19, 31].”
Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocations
Sugiura-Ogasawara, M., Ozaki, Y., Sato, T., Suzumori, N., & Suzumori, K. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.07.014 · Cited by 189 · cited 1×
“The detection of this translocation could be finely defined as the etiology of potential recurrent miscarriage [24, 25].”
ACOG PRACTICE BULLETIN: NO 24, FEB 2001, MANAGEMENT OF RECURRENT EARLY PREGNANCY LOSS
(2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00197-2 · Cited by 174
History of Miscarriage and Increased Incidence of Fetal Aneuploidy in Subsequent Pregnancy
Bianco, K., Caughey, A. B., Shaffer, B. L., Davis, R., & Norton, M. E. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000215560.86673.22 · Cited by 139
Recurrence risks for trisomies 13, 18, and 21
Souza, E. D., Halliday, J. L., Chan, A. C., Bower, C. I., & Morris, J. K. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33099 · Cited by 132
Research works printed but not linked: 1
- Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and treatment of couples with recurrent miscarriage. 2011. Available online at: http://www.rcog.org.uk .
Cited by
Recurrent MiscarriageGreen‐top Guideline No. 17
Regan, L., Rai, R., Saravelos, S., Li, T., & the Royal College of Obstetricians and Gynaecologists (2023) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17515 · Cited by 158
Papas, R. S., & Kutteh, W. H. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000647 · Cited by 53
Mümüşoğlu, S., Telek, S. B., & Ata, B. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.08.326 · Cited by 47
Papas, R. S., & Kutteh, W. H. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s320778 · Cited by 33
“The ESHRE recommends against its use for RPL couples without a genetic cause.(2,29,30) PGT-A has many limitations including a high cost, a risk of having no euploid embryo to transfer especially with advanced maternal age as well as possible embryo wastage and the presence of embryos with mosaicism of unknown clinical…”
MethodLi, H., Zhu, X., Yang, Y., Wang, W., Mao, A., Li, J., Bao, S., & Li, J. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117419 · Cited by 23
Self-citation
Metadata
- Authors
- Zhu, X., Li, J., Zhu, Y., Wang, W., Wu, X., Yang, Y., Gu, L., Gu, Y., & Hu, Y.
- Affiliations
- Nanjing Drum Tower Hospital (CN)
- Corresponding author
- Zhu, Xiangyu
- Hu, Yali
- Venue
- Molecular Cytogenetics
- Published
- 2018-08-17
- Volume
- 11
- Issue
- 1
- Pages
- 44-44
- ISSN
- 1755-8166 (ISSN-L)
- PMC
- PMC6098645
- OpenAlex
- W2887661378
- Cited by
- 29
- References
- 32
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 6 · 2023: 8 · 2022: 3 · 2021: 4 · 2020: 3
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Molecular Cytogenetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jiangsu Provincial Medical Youth Talent (QNRC2016030)
- Grant for Science and Technology Development (201605018)
- National Natural Science Foundation of China (81300490)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- chromosomal microarray analysis, products of conception, miscarriage, chromosomal abnormalities, copy number alterations, assisted reproduction, maternal age, adverse pregnancy history, detection rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Application of chromosomal microarray analysis in products of miscarriage. https://app.cochat.ai/papers/10.1186/s13039-018-0396-y
- The paper
- Zhu, X., Li, J., Zhu, Y., Wang, W., Wu, X., Yang, Y., Gu, L., Gu, Y., & Hu, Y. (2018). Application of chromosomal microarray analysis in products of miscarriage. Molecular Cytogenetics. https://doi.org/10.1186/s13039-018-0396-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.